Products for Research Use Only
RegisterLogin

Gabapentin-d4

CAT: 0804-HY-A0057SSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-A0057SSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Gabapentin-d4 is the deuterium labeled Gabapentin. Gabapentin (Neurontin) is a pharmaceutical agent, specifically a GABA analog. It was originally developed to treat epilepsy, and currently is also used to relieve neuropathic pain.
CAS Number
1185039-20-6
UNSPSC
12352211
Hazard Statement
H315, H319, H335, H360
Target
Calcium Channel
Type
Isotope-Labeled Compounds
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Purity
99.44
Solubility
10 mM in DMSO
Smiles
OC(C([2H])([2H])C1(CCCCC1)C([2H])([2H])N)=O
Molecular Formula
C9H13D4NO2
Molecular Weight
175.26
Precautions
H315, H319, H335, H360
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Pan CF, et al. Inhibitory mechanisms of gabapentin, an antiseizure drug, on platelet aggregation. J Pharm Pharmacol. 2007 Sep;59 (9) :1255-61.|[3]Gee NS, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem. 1996 Mar 8;271 (10) :5768-76.|[4]Abdel-Salam OM, et al. The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain. J Basic Clin Physiol Pharmacol. 2012;23 (2) :61-8.|[5]Yang JL, et al. Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats. Mol Brain. 2012 May 30;5:18.|[6]Zand L, et al. Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity. Am J Med. 2010 Apr;123 (4) :367-73.|[7]Hung TY, et al. Gabapentin toxicity: an important cause of altered consciousness in patients with uraemia. BMJ Case Rep. 2009;2009. pii: bcr11.2008.1268.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-A0057-01Gabapentin
HY-CE01790Gabapentin-CoA
HY-W721517-01Gabapentin-d10
HY-16216-01Gabapentin enacarbil
HY-A0057A-01Gabapentin (hydrochloride)
HY-A0057R-01Gabapentin (Standard)
HY-16216RGabapentin enacarbil (Standard)
HY-A0057AR-01Gabapentin (hydrochloride) (Standard)
HY-A0057ASGabapentin-d6 (hydrochloride)
HY-151912S-01Picolinafen-d4 (4-Fluorophenyl-d4)

Alternative Products

CatalogName
CS-T-55149Gabapentin-d4
CS-O-15443Gabapentin-d4 Hydrochloride
CS-O-06640Gabapentin-d4 Hydrochloride Monohydrate
CS-EL-00110Gabapentin-d4 (cyclohexyl-2,2,6,6-d4)
TRC-KIT1237-5X1MLGabapentin-d4 (100 μg/mL in Methanol)
G1016-61CGabapentin-d4 (1- (Aminomethyl) cyclohexaneacetic Acid-d4, Neurontin-d4, GOE-3450-d4)
MBS6017020-01Gabapentin-d4 (1-(Aminomethyl)cyclohexaneacetic Acid-d4, Neurontin-d4, GOE-3450-d4)
451032Gabapentin-d4 (100 μg/mL in Methanol) discontinued
T0702-01Gabapentin

Popular Products